Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034151
Status:
COMPLETED
Last Update Posted:
2009-06-04
First Post:
2002-04-23
Brief Title:
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
Sponsor:
Achieve Life Sciences
Organization:
Achieve Life Sciences
Organization Data
Organization:
Achieve Life Sciences
Class:
INDUSTRY
Study ID:
SON-8184-1061
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Achieve Life Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Monica Krieger VP Regulatory Affairs
Old Organization:
OncoGenex Pharmaceuticals